Aceto Corporation (ACET) Social Stream
ADICET BIO INC (ACET) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ADICET BIO INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 5 | $34 | $22 | $27 | $1.76 | 1434.09% |
| 2021-12-07 | 5 | $34 | $25 | $30.6 | $1.76 | 1638.64% |
| 2022-02-04 | 5 | $35 | $25 | $30.8 | $1.76 | 1650% |
| 2022-03-04 | 6 | $35 | $25 | $30.166 | $1.76 | 1613.98% |
| 2022-03-31 | 8 | $35 | $25 | $29.875 | $1.76 | 1597.44% |
| 2022-05-13 | 6 | $35 | $25 | $30.142 | $1.76 | 1612.61% |
| 2022-05-17 | 6 | $35 | $25 | $29.5 | $1.76 | 1576.14% |
| 2022-06-07 | 5 | $35 | $25 | $29.5 | $1.76 | 1576.14% |
| 2022-08-11 | 5 | $34 | $25 | $29.333 | $1.76 | 1566.65% |
| 2022-08-23 | 5 | $34 | $25 | $28.833 | $1.76 | 1538.24% |
| 2022-11-09 | 6 | $34 | $23 | $28 | $1.76 | 1490.91% |
| 2022-11-11 | 6 | $34 | $23 | $28.714 | $1.76 | 1531.48% |
| 2022-12-12 | 6 | $38 | $23 | $28.833 | $1.76 | 1538.24% |
| 2023-03-16 | 4 | $38 | $23 | $28.833 | $1.76 | 1538.24% |
| 2023-03-20 | 5 | $38 | $23 | $28.833 | $1.76 | 1538.24% |
| 2023-03-21 | 4 | $38 | $20 | $28.4 | $1.76 | 1513.64% |
| 2023-05-23 | 5 | $38 | $20 | $28.4 | $1.76 | 1513.64% |
| 2023-06-01 | 6 | $38 | $6 | $24.5 | $1.76 | 1292.05% |
| 2023-06-27 | 7 | $38 | $6 | $20.125 | $1.76 | 1043.47% |
| 2023-08-11 | 8 | $27 | $6 | $18.625 | $1.76 | 958.24% |
| 2023-09-05 | 8 | $27 | $6 | $17.375 | $1.76 | 887.22% |
| 2023-11-09 | 9 | $27 | $5 | $16.444 | $1.76 | 834.32% |
| 2023-11-10 | 9 | $27 | $5 | $17.125 | $1.76 | 873.01% |
| 2023-11-14 | 9 | $27 | $5 | $16.625 | $1.76 | 844.6% |
The Trend in the Analyst Price Target
ACET's average price target has moved down $11.38 over the prior 12 months.
ACET reports an average of 703.64% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-21 | 5 | 38 | 20 | 28.333 | 6.57 | 331.25% |
| 2023-09-05 | 8 | 27 | 6 | 17.375 | 1.86 | 834.14% |
| 2023-11-14 | 10 | 27 | 5 | 16.625 | 1.18 | 1308.9% |
| 2023-11-14 | 9 | 27 | 5 | 16.625 | 1.18 | 1308.9% |
| 2023-11-14 | 10 | 27 | 5 | 17.333 | 1.18 | 1368.9% |
ACET Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.6 | 7 | 0 | 3 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 38 months, ACET's average broker recommendation rating worsened by 0.67.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, ADICET BIO INC's upside potential (average analyst target price relative to current price) is higher than 3132.54% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ADICET BIO INC's variance in analysts' estimates is lower than -1356.07% of them.
- ACET has a greater number of analysts covering the stock than 2253.21% of stocks in the small market cap category.
- ADICET BIO INC's average analyst price target is greater than 2099.6% of stocks in the small market cap category.
Stocks similar to ADICET BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are KZIA, VYNE, and CUE.
View All Top Stocks by Price Target
Make investment decisions regarding ACET using the data that counts. Try POWR Ratings for free.